Teva Pharmaceutical Industries Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$15.87B N/A	$14.92B -6.00%	$15.84B 6.17%	Avg: $16.55B Low: $16.55B High: $16.55B avg. 4.49%	Avg: $16.94B Low: $16.94B High: $16.94B avg. 2.35%	Avg: $16.42B Low: $16.42B High: $16.42B avg. -3.11%
Net Income % change YoY	$417M N/A	$-2.35B -664.26%	$-559M 76.24%	Avg: $3.04B Low: $3.04B High: $3.04B avg. 645.32%	Avg: $3.25B Low: $3.25B High: $3.25B avg. 6.92%	Avg: $3.55B Low: $3.55B High: $3.55B avg. 8.92%
EBITDA % change YoY	$4.52B N/A	$4.10B -9.34%	$1.55B -62.04%	Avg: $4.29B Low: $4.29B High: $4.29B avg. 175.58%	Avg: $4.39B Low: $4.39B High: $4.39B avg. 2.35%	Avg: $4.25B Low: $4.25B High: $4.25B avg. -3.11%
EPS % change YoY	$0.38 N/A	-$2.12 -657.89%	-$0.5 76.41%	Avg: $2.72 Low: $2.72 High: $2.72 avg. 644.83%	Avg: $2.91 Low: $2.91 High: $2.91 avg. 6.92%	Avg: $3.17 Low: $3.17 High: $3.17 avg. 8.92%
Operating Expenses % change YoY	$4.49B N/A	$4.28B -4.71%	$7.21B 68.40%	Avg: $3.70B Low: $3.70B High: $3.70B avg. -48.60%	Avg: $3.79B Low: $3.79B High: $3.79B avg. 2.35%	Avg: $3.67B Low: $3.67B High: $3.67B avg. -3.11%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 220.39% in 2025-2027.

We have gathered data from N/A analysts. Their low estimate is 3.04B, average is 3.04B and high is 3.04B.

Wall Street analysts forecast annual average revenue growth of 1.24% in 2025-2027.

We have gathered data from N/A analysts. Their low revenue estimate is $16.55B, average is $16.55B and high is $16.55B.

Wall Street analysts forecast annual average earnings growth of 220.23% in 2025-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $2.72, average is $2.72 and high is $2.72.